Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PARP10 | Q53GL7 | 2/20 | 0.49 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.46 |
| ▸ | NR1H4 | Q96RI1 | 1/20 | 0.38 |
| ▸ | MLYCD | O95822 | 1/20 | 0.38 |
| ▸ | ELANE | P08246 | 4/20 | 0.37 |
| ▸ | MEN1 | O00255 | 1/20 | 0.36 |
| ▸ | CA1 | P00915 | 1/20 | 0.36 |
| ▸ | CA2 | P00918 | 1/20 | 0.36 |
| ▸ | PARP1 | P09874 | 1/20 | 0.36 |
| ▸ | PARP2 | Q9UGN5 | 1/20 | 0.36 |
| ▸ | PARP4 | Q9UKK3 | 1/20 | 0.36 |
| ▸ | POLB | P06746 | 2/20 | 0.35 |
| ▸ | LMNA | P02545 | 2/20 | 0.35 |
| ▸ | MAPT | P10636 | 2/20 | 0.35 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.35 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.35 |
| ▸ | GAA | P10253 | 1/20 | 0.35 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.35 |
| ▸ | PKM | P14618 | 1/20 | 0.35 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1007396 | 0.87 | PARP10 (0.50) | PARP10KMT2ANR1H4MLYCDELANE | |
| SCHEMBL402379 | 0.87 | KMT2A (0.61) | PARP10KMT2ANR1H4MEN1POLB | |
| SCHEMBL18628868 | 0.81 | KMT2A (0.39) | PARP10KMT2ANR1H4ELANEPOLB | |
| SCHEMBL13850448 | 0.80 | KMT2A (0.41) | PARP10KMT2ANR1H4MLYCDELANE | |
| SCHEMBL9421824 | 0.79 | KMT2A (0.44) | PARP10KMT2ANR1H4MEN1POLB | |
| SCHEMBL195348 | 0.79 | HPGD (0.56) | PARP10KMT2AELANEPARP4MAPT | |
| SCHEMBL10591230 | 0.79 | ELANE (0.57) | PARP10KMT2AELANEMEN1CA1 | |
| SCHEMBL305364 | 0.78 | LMNA (0.51) | POLBLMNAMAPTNPSR1GAA | |
| SCHEMBL11298330 | 0.78 | CA2 (0.46) | MLYCDELANECA2LMNASMN1; SMN2 | |
| SCHEMBL13180698 | 0.78 | CYP1A2 (0.40) | PARP10KMT2ANR1H4MLYCDMEN1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 880 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3685231-B1 | 3D PRINTING WITH POLYMERIC NANOGEL PARTICLES | THE REGENTS OF THE UNIV OF COLORADO A BODY CORPORATE A COLORADO NON PROFIT (US) | 2026-05-13 | — | — | EP | claimed |
| EP-4565378-B1 | METHODS FOR PRODUCING OPTICAL EFFECT LAYERS COMPRISING MAGNETIC OR MAGNETIZABLE PIGMENT PARTICLES AND EXHIBITING ONE OR MORE INDICIA | SICPA HOLDING SA (CH) | 2026-05-06 | — | — | EP | claimed |
| US-20260048177-A1 | ORGANIC SOLVENT FREE COMPOSITIONS COMPRISING PROTEIN-POLYMER CONJUGATES AND USES THEREOF | REGENTIS BIOMATERIALS LTD. (IL) | 2026-02-19 | — | — | US | claimed |
| US-20260015799-A1 | METHODS FOR PRODUCING OPTICAL EFFECT LAYERS COMPRISING MAGNETIC OR MAGNETIZABLE PIGMENT PARTICLES AND EXHIBITING ONE OR MORE INDICIA | SICPA HOLDING SA (CH) | 2026-01-15 | — | — | US | claimed |
| US-20250276022-A1 | DENTIN MATRIX PROTEIN MATERIALS AND ASSOCIATED METHODS | UNIV OREGON HEALTH & SCIENCE (US) | 2025-09-04 | — | — | US | claimed |
| US-20250187036-A1 | METHODS FOR PRODUCING OPTICAL EFFECT LAYERS COMPRISING MAGNETIC OR MAGNETIZABLE PIGMENT PARTICLES AND EXHIBITING ONE OR MORE INDICIA | SICPA HOLDING SA (CH) | 2025-06-12 | — | — | US | claimed |
| EP-4565378-A1 | METHODS FOR PRODUCING OPTICAL EFFECT LAYERS COMPRISING MAGNETIC OR MAGNETIZABLE PIGMENT PARTICLES AND EXHIBITING ONE OR MORE INDICIA | Sicpa Holding SA (CH) | 2025-06-11 | — | — | EP | claimed |
| EP-4486515-A1 | METHODS FOR PRODUCING OPTICAL EFFECT LAYERS COMPRISING MAGNETIC OR MAGNETIZABLE PIGMENT PARTICLES AND EXHIBITING ONE OR MORE INDICIA | Sicpa Holding SA (CH) | 2025-01-08 | — | — | EP | claimed |
| US-12168072-B2 | Optically-induced auto-encapsulation | Prellis Biologics, Inc. (US) | 2024-12-17 | — | — | US | claimed |
| US-12064346-B2 | System and method for implanting and securing a bioprosthetic device to wet tissue | EDWARDS LIFESCIENCES CORPORATION (US) | 2024-08-20 | — | — | US | claimed |
| US-7192693-B2 | Methods for photopatterning hydrogels | UNIVERSITY OF WASHINGTON (US) | 2007-03-20 | — | — | US | claimed |
| US-20050196702-A1 | degradable crosslinking agents for forming degradable, porous, photopatterned hydrogels; for immobilizing biologically active molecules; useful in a variety of medical applications | NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT | 2005-09-08 | — | — | US | claimed |
| US-20050118425-A1 | Microcapsules containing biomedical materials | MCMASTER UNIVERSITY (CA) | 2005-06-02 | — | — | US | claimed |
| US-6861205-B2 | Three dimensional microstructures and method of making | BATTELLE MEMORIAL INSTITUTE (US) | 2005-03-01 | — | — | US | claimed |
| EP-1226183-B1 | PREPARATION OF LOW RESIDUAL MONOMER CONTENT POLYMERS | CYTEC TECH CORP (US) | 2004-08-18 | — | — | EP | claimed |
| WO-2003094898-A2 | MICROCAPSULES CONTAINING BIOMEDICAL MATERIALS | MCMASTER UNIVERSITY (CA) | 2003-11-20 | — | — | WO | claimed |
| US-20030148222-A1 | Three dimensional microstructures and method of making | BATTELLE MEMORIAL INSTITUTE | 2003-08-07 | — | — | US | claimed |
| EP-1226183-A1 | PREPARATION OF LOW RESIDUAL MONOMER CONTENT POLYMERS | CYTEC TECHNOLOGY CORP. (US) | 2002-07-31 | — | — | EP | claimed |
| US-6262141-B1 | FORMING GELLED POLYMER BY POLYMERIZING MIXTURE CONTAINING ACRYLIC MONOMER AND PHOTOINITIATOR IN ABSENCE OF APPLIED ULTRAVIOLET RADIATION; COMMINUTING TO PRODUCE GEL PARTICLES; IRRADIATING WITH LIGHT TO DECOMPOSE PHOTOINITIATOR | CYTEC TECHNOLOGY CORPORATION | 2001-07-17 | — | — | US | claimed |
| WO-2001025289-A1 | PREPARATION OF LOW RESIDUAL MONOMER CONTENT POLYMERS | CYTEC TECHNOLOGY CORP. (US) | 2001-04-12 | — | — | WO | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20260048177-A1 | ORGANIC SOLVENT FREE COMPOSITIONS COMPRISING PROTEIN-POLYMER CONJUGATES AND USES THEREOF | FGB, F12, F11 | PARP10 3017/4885KMT2A 4498/4885NR1H4 3260/4885 |
| US-20260015799-A1 | METHODS FOR PRODUCING OPTICAL EFFECT LAYERS COMPRISING MAGNETIC OR MAGNETIZABLE PIGMENT PARTICLES AND EXHIBITING ONE OR MORE INDICIA | IK, TEX10, INCENP | PARP10 795/4885KMT2A 3140/4885NR1H4 4134/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.